Association of visceral fat area with chronic kidney disease and metabolic syndrome risk in the general population: Analysis using multi-frequency bioimpedance

Kidney and Blood Pressure Research

Volumn 40, Issue 3, 2015, Pages 223-230

  Kang, Seok Hui ^a   Cho, Kyu Hyang ^a   Park, Jong Won ^a   Yoon, Kyung Woo ^a   Do, Jun Young ^a  

^a Young Nam University Hospital   (South Korea)

Author keywords

Bioimpedance analysis; Chronic kidney disease; Metabolic syndrome; Visceral fat

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOIMPEDANCE ANALYSIS; BLOOD PRESSURE; BODY FAT; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FAT MASS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LEAN BODY WEIGHT; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; URIC ACID BLOOD LEVEL; VISCERAL FAT AREA; WAIST HIP RATIO; AGED; BODY MASS; DIABETES MELLITUS, TYPE 2; IMPEDANCE; INTRAABDOMINAL FAT; PATHOLOGY; PREDICTIVE VALUE; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SOUTH KOREA;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; ELECTRIC IMPEDANCE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; INTRA-ABDOMINAL FAT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; REPUBLIC OF KOREA; RISK ASSESSMENT; WAIST-HIP RATIO;

EID: 84929688642     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000368498     Document Type: Article

References (33)

1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G: Chronic kidney disease as a global public health problem: approaches and initiatives -a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007;72:247-259.
2. US Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013.
3. Jin DC, Han JS: Renal replacement therapy in Korea, 2012. Kidney Res Clin Pract 2014;33:9-18.
4. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL: Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003;14:479-487.
5. Iseki J, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of endstage renal disease in a screened cohort. Kidney Int 2004;65:1870-1876.
6. Lucove J, Vupputuri S, Heiss G, North K, Russell M: Metabolic syndrome and the development of CKD in American Indians: The Strong Heart Study. Am J Kidney Dis 2008;51:21-28.
7. Kang YU, Kim HY, Choi JS, Kim CS, Bae EH, Ma SK, Kim SW: Metabolic syndrome and chronic kidney disease in an adult Korean population: results from the Korean national health screening. PLoS One 2014;9:e93795.
8. Singh AK, Kari JA: Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2013;22:198-203.
9. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB Sr, O'Donnell CJ: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48.
10. Hajer GR, van Haeften TW, Visseren FL: Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008;29:2959-2971.
11. Burton JO, Gray LJ, Webb DR, Davies MJ, Khunti K, Crasto W, Carr SJ, Brunskill NJ: Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population. Nephrol Dial Tranplant 2012;27:1860-1866.
12. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 2006;144:21-28.
13. Vupputuri S, Fox CS, Coresh J, Woodward M, Muntner P: Differential estimation of CKD using creatinineversus cystatin C-based estimating equations by category of body mass index. Am J Kidney Dis 2009;53:993-1001.
14. Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, Levey AS, Weiner DE: Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 2008;52:29-38.
15. Noori N, Hosseinpanah F, Nasiri AA, Azizi F: Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr 2009;19:228-237.
16. Jackson AS, Pollock ML, Graves JE, Mahar MT: Reliability and validity of bioelectrical impedance in determining body composition. J Appl Physiol 1988;64:529-534.
17. Zillikens MC, van den Berg JW, Wilson JH, Rietveld T, Swart GR: The validity of bioelectrical impedance analysis in estimating total body water in patients with cirrhosis. J Hepatol 1992;16:59-65.
18. Malavolti M, Mussi C, Poli M, Fantuzzi AL, Salvioli G, Battistini N, Bedogni G: Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years. Ann Hum Biol 2003;30:380-391.
19. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
20. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute: Diagnostic and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
21. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
22. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004;140:167-174.
23. Clark AL, Chyu J, Horwich TB: The obesity paradox in men versus women with systolic heart failure. Am J Cardiol 2012;110:77-82.
24. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM: The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165:55-61.
25. Dhoot J, Tariq S, Erande A, Amin A, Patel P, Malik S: Effect of morbid obesity on in-hospital mortality and coronary revascularization outcomes after acute myocardial infarction in the United States. Am J Cariol 2013;111:1104-1110.
26. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J Jr: The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002;39:578-584.
27. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharm AM, Anand SS; INTERHEART Study Investigators: Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-1649.
28. Velludo CM, Kamimura MA, Sanches FM, Lemos MM, Canziani ME, Pupim LB, Draibe SA, Cuppari L: Prospective evaluation of waist circumference and visceral adipose tissue with chronic kidney disease. Am J Nephrol 2010;31:104-109.
29. Zoccali C, Torino C, Tripepi G, Mallamaci F: Assessment of obesity in chronic kidney disease: what is the best measure? Curr Opin Nephrol Hypertens 2012;21:641-646.
30. Ogawa H, Fujitani K, Tsujinaka T, Imanishi K, Shirakata H, Kantani A, Hirao M, Kurokawa Y, Utsumi S: InBody 720 as a new method of evaluating visceral obesity. Hepatogastroenterology 2011;58:42-44.
31. Torimoto K, Samma S, Kagebayashi Y, Chihara Y, Tanaka N, Hirayama A, Fujimoto K, Hirao Y: The effects of androgen deprivation therapy on lipid metabolism and body composition in Japanese patients with prostate cancer. Jpn J Clin Oncol 2011;41:577-581.
32. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gómez J, Lilienthal Heitmann B, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, M W J Schols A, Pichard C; ESPEN: Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004;23:1430-1453.
33. Mialich MS, Sicchieri JMF, Junior AAJ: Analysis of body composition: a critical review of the use of bioelectricial impedance analysis. Int J Clin Nutr 2014;2:1-10.